{
  "source": "facebook",
  "source_id": "001",
  "url": "https://www.facebook.com/AmylyxPharma/posts/001",
  "title": null,
  "text": "Amylyx Pharmaceuticals is enrolling patients in a Phase 3 clinical trial for avexitide, an investigational treatment for post-bariatric hypoglycemia (PBH). If you've had bariatric surgery and experience low blood sugar episodes after meals, you may be eligible. Visit our website to learn more about participation. #ClinicalTrial #PBH #BariatricSurgery",
  "parent_source": null,
  "subsource": "Amylyx Pharmaceuticals",
  "author": {
    "id": "fb_user_001",
    "name": "User M",
    "handle": "user_m",
    "gender": null,
    "age": null,
    "subscribers": 15200
  },
  "country": "US",
  "language": "eng",
  "metrics": {
    "likes": 124,
    "comments": 38,
    "shares": 22
  },
  "sentiment": null,
  "published_at": "2025-04-25T10:00:00+00:00"
}